MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation

MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation

Diagnosis and treatment of prostate cancer (PCа) are associated with the serum level of prostate specific antigen (PSA). However, certain prostate diseases such as benign prostatic hyperplasia (BPH) and prostatitis can also affect PSA levels. The low specificity and sensitivity of PSA leads to a &qu...

Full description

Bibliographic Details
Main Authors: Z. M. Akhokhov, R. S. Ismailov, M. I. Kogan
Format: Article
Language:Russian
Published: State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2023-10-01
Series:Vestnik Urologii
Subjects:
mirna
benign prostatic hyperplasia
prostate cancer
lower urinary tract symptoms
prostate specific antigen
molecular biological markers
ribonucleic acid
review
Online Access:https://www.urovest.ru/jour/article/view/760

Similar Items

Similar Items